trending Market Intelligence /marketintelligence/en/news-insights/trending/VwwKZsuolKnEyvET4i4biA2 content esgSubNav
In This List

Valeant unit receives US FDA clearance for cataract surgery platform

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Valeant unit receives US FDA clearance for cataract surgery platform

The U.S. FDA cleared Bausch & Lomb's Stellaris Elite Vision Enhancement System.

The Valeant Pharmaceuticals International Inc. unit received 510(k) clearance for the system, which facilitates cataract surgery by allowing surgeons to further customize their machines.